Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2
The experimentally established mechanism targets of Octanoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 7/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decanoic Acid SCHEMBL580470 | 1.00 | FABP3 (0.55) | FABP3CA1BBOX1CES2CES1 | |
| Nonanoate SCHEMBL29370695 | 1.00 | FABP3 (0.55) | FABP3CA1BBOX1CES2CES1 | |
| Stearic Acid SCHEMBL840883 | 1.00 | FABP3 (0.55) | FABP3CA1BBOX1CES2CES1 | |
| Dodecanoate SCHEMBL19253062 | 1.00 | FABP3 (0.55) | FABP3CA1BBOX1CES2CES1 | |
| Palmitic Acid SCHEMBL10396224 | 1.00 | FABP3 (0.55) | FABP3CA1BBOX1CES2CES1 | |
| Myristic Acid SCHEMBL8588822 | 1.00 | FABP3 (0.55) | FABP3CA1BBOX1CES2CES1 | |
| Stearic Acid SCHEMBL3459529 | 0.98 | FABP3 (0.53) | FABP3CA1BBOX1CES2CES1 | |
| Myristic Acid SCHEMBL5317287 | 0.98 | FABP3 (0.53) | FABP3CA1BBOX1CES2CES1 | |
| Dodecanoate SCHEMBL5320074 | 0.98 | FABP3 (0.53) | FABP3CA1BBOX1CES2CES1 | |
| Decanoic Acid SCHEMBL5318916 | 0.98 | FABP3 (0.53) | FABP3CA1BBOX1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118058284-A | Fatty acid choline salt soluble solution and preparation method and application thereof | 郑州郑氏化工产品有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-113939273-A | Ionic liquids for drug delivery | 哈佛大学校长及研究员协会 | 2022-01-14 | — | — | CN | claimed |
| EP-3883382-A1 | COMPOSITION COMPRISING A CHOLINE SALT OF A FATTY ACID AND ITS USE AS A FUNGICIDE | BIPA NV (BE) | 2021-09-29 | — | — | EP | claimed |
| CN-113163761-A | Compositions comprising choline salts of fatty acids and their use as fungicides | 比帕股份有限公司 | 2021-07-23 | — | — | CN | claimed |
| WO-2010136105-A2 | AMMONIUMCARBOXYLATES | MERCK PATENT GMBH (DE) | 2010-12-02 | — | — | WO | claimed |
| US-20260034075-A1 | CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS | UNIV MISSISSIPPI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250354930-A1 | IONIC LIQUID ENCAPSULATION OF NIR DYES FOR THE IMPROVEMENT OF BLOODSTAIN DETECTION | UNIV MISSISSIPPI (US) | 2025-11-20 | — | — | US | disclosed |
| US-12446577-B2 | Composition comprising a choline salt of a fatty acid and its use as a fungicide | BIPA NV (BE) | 2025-10-21 | — | — | US | disclosed |
| US-12441959-B2 | Composition containing organic ammonium salt | MIYOSHI OIL & FAT CO., LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| EP-4588995-A1 | IMPROVEMENT OF SOLUBILITY OF CHOLINE CARBOXYLATES IN BASE OILS | OLEON NV (BE) | 2025-07-23 | — | — | EP | disclosed |
| CN-118058284-A | Fatty acid choline salt soluble solution and preparation method and application thereof | 郑州郑氏化工产品有限公司 | 2024-05-24 | — | — | CN | disclosed |
| WO-2024044526-A1 | RED BLOOD CELL-HITCHHIKING IONIC LIQUID COATED NANOPARTICLES FOR CROSSING THE BLOOD BRAIN BARRIER | UNIVERSITY OF MISSISSIPPI (US) | 2024-02-29 | — | — | WO | disclosed |
| US-9949475-B2 | Composition comprising active ingredient, oil and ionic liquid | BASF SE (DE) | 2018-04-24 | — | — | US | disclosed |
| CN-107810204-A | For terminating the composition of radical polymerization immediately | 巴斯夫欧洲公司 | 2018-03-16 | — | — | CN | disclosed |
| WO-2016202883-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2016-12-22 | — | — | WO | disclosed |
| US-20150004109-A1 | COMPOSITION COMPRISING ACTIVE INGREDIENT, OIL AND IONIC LIQUID | BASF SE (DE) | 2015-01-01 | — | — | US | disclosed |
| WO-2014128009-A1 | AQUEOUS AGROCHEMICAL COMPOSITION COMPRISING A PESTICIDE IN SUSPENDED FORM, A DISPERSANT, AND AN IONIC LIQUID | BASF SE (DE) | 2014-08-28 | — | — | WO | disclosed |
| EP-2744335-A1 | COMPOSITION COMPRISING ACTIVE INGREDIENT, OIL AND IONIC LIQUID | BASF SE (DE) | 2014-06-25 | — | — | EP | disclosed |
| WO-2013024099-A1 | COMPOSITION COMPRISING ACTIVE INGREDIENT, OIL AND IONIC LIQUID | BASF SE (DE) | 2013-02-21 | — | — | WO | disclosed |
| CN-1638879-A | Silicone resin based composites interleaved for improved toughness | MASSACHUSETTS INST TECHNOLOGY (US) | 2005-07-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441959-B2 | Composition containing organic ammonium salt | SLC6A15, SLC38A7, SLC6A19 | FABP3 532/4885CA1 625/4885BBOX1 3810/4885 |
| US-20150004109-A1 | COMPOSITION COMPRISING ACTIVE INGREDIENT, OIL AND IONIC LIQUID | PLA2G2C, CEL, LIPA | FABP3 1469/4885CA1 1411/4885BBOX1 1972/4885 |
| US-20260034075-A1 | CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS | ELOVL3, L3MBTL3, ELOVL6 | FABP3 79/4885CA1 1831/4885BBOX1 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.